(Q30356450)

20 June 2017

1 reference

title

Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. (English)

1 reference

20 June 2017

main subject

cardiovascular disease

1 reference

Steven M Haffner

1 reference

20 June 2017

publication date

1 June 2006

1 reference

20 June 2017

1 reference

20 June 2017

volume

14 Suppl 3

1 reference

20 June 2017

page(s)

121S-127S

1 reference

Weight gain as a risk factor for clinical diabetes mellitus in women

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Body weight, weight change, and risk for hypertension in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

The continuing epidemics of obesity and diabetes in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Diabetes trends in the U.S.: 1990-1998.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

The spread of the obesity epidemic in the United States, 1991-1998

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Body fat distribution and 5-year risk of death in older women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Guidelines for healthy weight

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Weight, diet, and the risk of symptomatic gallstones in middle-aged women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Clustering of metabolic factors and coronary heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Banting lecture 1988. Role of insulin resistance in human disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Obesity and the metabolic syndrome in children and adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Treatment strategies in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

Lowering the criterion for impaired fasting glucose is in order

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.291

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.291

1 reference

20 June 2017

1 reference